MRI Shows Brain Anatomy Differences Between Autistic and Typically Developing Individuals to Be Mostly Indistinguishable
|
By MedImaging International staff writers Posted on 24 Nov 2014 |

Image: Differences in the brains of autistic and control subjects using MRI (Photo courtesy of Center of Cognitive Brain Imaging, Carnegie Mellon University).

Image: MR diffusion spectrum imaging (DSI) used to examine the structural integrity of white matter in people with autism and typical participants. These imaging techniques visualize axonal tracts by measuring the diffusion of water along white matter fibers (Photo courtesy of Center of Cognitive Brain Imaging, Carnegie Mellon University).
In the largest magnetic resonance imaging (MRI) study of patients with autism to date, Israeli and American researchers have shown that the brain anatomy in MRI scans of autistic individuals older than age six is mostly indistinguishable from that of typically developing individuals, and therefore, of little clinical or scientific value.
The researchers from Ben-Gurion University of the Negev (BGU; Be’er Sheva, Israel) and Carnegie Mellon University (Pittsburgh, PA, USA) published their findings online October 14, 2014, in the Oxford journal Cerebral Cortex. “Our findings offer definitive answers regarding several scientific controversies about brain anatomy, which have occupied autism research for the past 10 to 15 years,” said Dr. Ilan Dinstein of BGU’s departments of psychology and brain and cognitive sciences. “Previous hypotheses suggesting that autism is associated with larger intracranial gray matter, white matter, and amygdala volumes, or smaller cerebellar, corpus callosum and hippocampus volumes were mostly refuted by this new study.”
The researchers used data from the Autism Brain Imaging Data Exchange (ABIDE), which provides an unprecedented prospect to conduct large-scale comparisons of anatomic MRI scans across autism and control groups and resolve many outstanding questions. This recently released database is a worldwide collection of MRI scans from over 1,000 individuals (half with autism and half controls) ages 6 to 35 years old.
“In the study we performed very detailed anatomical examinations of the scans, which included dividing each brain into over 180 regions of interest and assessing multiple anatomical measures such as the volume, surface area and thickness of each region,” Dr. Dinstein stated.
The researchers then examined how the autism and control groups differed with respect to each region and also with respect to groups of regions using more complex analyses. “The most striking finding here was that anatomical differences within both the control group and the autistic group was immense and greatly overshadowed minute differences between the two groups,” Dr. Dinstein noted. “For example, individuals in the control group differ by 80% to 90% in their brain volumes, while differences in brain volume across autism and control groups differed by 2% to 3% percent at most. This led us to the conclusion that anatomical measures of brain volume or surface areas do not offer much information regarding the underlying mechanism or pathology of autistic spectrum disorder [ASD],” he stated. “These sobering results suggest that autism is not a disorder that is associated with specific anatomical pathology and as a result, anatomical measures alone are likely to be of low scientific and clinical significance for identifying children, adolescents and adults with ASD, or for elucidating their neuropathology.”
Dr. Dinstein believes that more complicated explanations involving combinations of measures in more homogeneous subgroups are in all probability to be the answer. “Expecting to find a single answer for the entire ASD population is naive. We need to move on to thinking about how to split up this very heterogeneous group of disorders into more meaningful biologically-relevant subgroups,” he stated.
This conclusion stands in great contrast to numerous reports of significant anatomical differences described by smaller studies, which have typically included comparisons of 40 to 50 individuals. “The problem with small samples, large within-group heterogeneity, and a scientific bias to report only positive findings, is that small samples are likely to yield significant differences across autism and control groups in a few of the 180 brain regions,” Dr. Dinstein explained.
“In such a situation one would expect that each study would find significant differences in different brain areas and that findings will be very inconsistent across studies," he says. "This is exactly what you see when you examine the autism anatomy literature from the last decade or so. Our study simply explains why this has been happening and puts an end to several ensuing debates.”
Related Links:
Ben-Gurion University of the Negev
Center of Cognitive Brain Imaging, Carnegie Mellon University
Carnegie Mellon University
The researchers from Ben-Gurion University of the Negev (BGU; Be’er Sheva, Israel) and Carnegie Mellon University (Pittsburgh, PA, USA) published their findings online October 14, 2014, in the Oxford journal Cerebral Cortex. “Our findings offer definitive answers regarding several scientific controversies about brain anatomy, which have occupied autism research for the past 10 to 15 years,” said Dr. Ilan Dinstein of BGU’s departments of psychology and brain and cognitive sciences. “Previous hypotheses suggesting that autism is associated with larger intracranial gray matter, white matter, and amygdala volumes, or smaller cerebellar, corpus callosum and hippocampus volumes were mostly refuted by this new study.”
The researchers used data from the Autism Brain Imaging Data Exchange (ABIDE), which provides an unprecedented prospect to conduct large-scale comparisons of anatomic MRI scans across autism and control groups and resolve many outstanding questions. This recently released database is a worldwide collection of MRI scans from over 1,000 individuals (half with autism and half controls) ages 6 to 35 years old.
“In the study we performed very detailed anatomical examinations of the scans, which included dividing each brain into over 180 regions of interest and assessing multiple anatomical measures such as the volume, surface area and thickness of each region,” Dr. Dinstein stated.
The researchers then examined how the autism and control groups differed with respect to each region and also with respect to groups of regions using more complex analyses. “The most striking finding here was that anatomical differences within both the control group and the autistic group was immense and greatly overshadowed minute differences between the two groups,” Dr. Dinstein noted. “For example, individuals in the control group differ by 80% to 90% in their brain volumes, while differences in brain volume across autism and control groups differed by 2% to 3% percent at most. This led us to the conclusion that anatomical measures of brain volume or surface areas do not offer much information regarding the underlying mechanism or pathology of autistic spectrum disorder [ASD],” he stated. “These sobering results suggest that autism is not a disorder that is associated with specific anatomical pathology and as a result, anatomical measures alone are likely to be of low scientific and clinical significance for identifying children, adolescents and adults with ASD, or for elucidating their neuropathology.”
Dr. Dinstein believes that more complicated explanations involving combinations of measures in more homogeneous subgroups are in all probability to be the answer. “Expecting to find a single answer for the entire ASD population is naive. We need to move on to thinking about how to split up this very heterogeneous group of disorders into more meaningful biologically-relevant subgroups,” he stated.
This conclusion stands in great contrast to numerous reports of significant anatomical differences described by smaller studies, which have typically included comparisons of 40 to 50 individuals. “The problem with small samples, large within-group heterogeneity, and a scientific bias to report only positive findings, is that small samples are likely to yield significant differences across autism and control groups in a few of the 180 brain regions,” Dr. Dinstein explained.
“In such a situation one would expect that each study would find significant differences in different brain areas and that findings will be very inconsistent across studies," he says. "This is exactly what you see when you examine the autism anatomy literature from the last decade or so. Our study simply explains why this has been happening and puts an end to several ensuing debates.”
Related Links:
Ben-Gurion University of the Negev
Center of Cognitive Brain Imaging, Carnegie Mellon University
Carnegie Mellon University
Latest MRI News
- MRI-Derived Biomarker Improves Risk Stratification in Glioblastoma
- Combined Imaging Approach Identifies Cause of Heart Attack without Coronary Blockage
- Advanced MRI System Detects Impaired Cardiac Oxygen Use in Minutes
- AI-Enhanced MRI Improves Image Quality in Arrhythmia Patients
- Ultra-Detailed Brain Atlas Enhances Early Detection of Neurological Disorders
- Study Finds Advanced Imaging Significantly Reduces Unnecessary Prostate Biopsies
- New Material Boosts MRI Image Quality
- AI Model Reads and Diagnoses Brain MRI in Seconds
- MRI Scan Breakthrough to Help Avoid Risky Invasive Tests for Heart Patients
- MRI Scans Reveal Signature Patterns of Brain Activity to Predict Recovery from TBI
- Novel Imaging Approach to Improve Treatment for Spinal Cord Injuries
- AI-Assisted Model Enhances MRI Heart Scans
- AI Model Outperforms Doctors at Identifying Patients Most At-Risk of Cardiac Arrest
- New MRI Technique Reveals Hidden Heart Issues
- Shorter MRI Exam Effectively Detects Cancer in Dense Breasts
- MRI to Replace Painful Spinal Tap for Faster MS Diagnosis
Channels
Radiography
view channel
AI Boosts Breast Cancer Detection and Cuts Screening Workload
Breast cancer screening programs face rising demand and persistent workforce shortages, straining double-reading workflows and delaying care. Early detection is critical to reduce mortality and minimize... Read more
AI Tool Predicts Breast Cancer Risk Years Ahead Using Routine Mammograms
Breast cancer screening saves lives but still relies largely on uniform schedules despite wide differences in individual risk. This one-size-fits-all approach can miss cancers in higher-risk women while... Read moreUltrasound
view channel
New Ultrasound AI Tool Supports Rapid Prenatal Assessment
Accurate gestational age estimation guides prenatal screening, detection of complications, and timely intervention. Access to ultrasound and trained sonographers is uneven, with nearly half of U.... Read more
New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
Metabolic dysfunction-associated steatotic liver disease (MASLD) is rising along with obesity and diabetes, making accurate, scalable measurement of hepatic fat a clinical priority. Biopsy is invasive... Read moreNuclear Medicine
view channel
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channel
AI Tool Predicts Side Effects from Lung Cancer Treatment
Radiation therapy is a central treatment for lung cancer, but even carefully targeted radiation can affect surrounding healthy tissue. Patients may develop side effects such as lung inflammation, coughing,... Read more
AI Tool Offers Prognosis for Patients with Head and Neck Cancer
Oropharyngeal cancer is a form of head and neck cancer that can spread through lymph nodes, significantly affecting survival and treatment decisions. Current therapies often involve combinations of surgery,... Read moreImaging IT
view channel
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more




 Guided Devices.jpg)


